What was the overall market valuation for viral gastroenteritis in 2024?

The overall market valuation for viral gastroenteritis was $475.0 Million in 2024. Read More

What is the projected market valuation for viral gastroenteritis by 2035?

The projected market valuation for viral gastroenteritis is $800.0 Million by 2035. Read More

What is the expected CAGR for the US viral gastroenteritis market during the forecast period 2025 - 2035?

The expected CAGR for the US viral gastroenteritis market during the forecast period 2025 - 2035 is 4.85%. Read More

Which companies are considered key players in the viral gastroenteritis market?

Key players in the viral gastroenteritis market include GSK, Merck & Co, Pfizer, Sanofi, Bristol-Myers Squibb, Johnson & Johnson, AbbVie, and AstraZeneca. Read More

What are the market segments based on the type of virus causing gastroenteritis?

Market segments based on the type of virus include Norovirus ($200.0 - $350.0 Million), Rotavirus ($150.0 - $250.0 Million), Adenovirus ($75.0 - $120.0 Million), and Sapovirus ($50.0 - $80.0 Million). Read More

How is the viral gastroenteritis market segmented by transmission route?

The market is segmented by transmission route, with Fecal-Oral Route valued at $190.0 - $320.0 Million, Contaminated Water at $150.0 - $250.0 Million, and Contaminated Food at $135.0 - $230.0 Million. Read More

What age groups are most affected by viral gastroenteritis, according to market data?

The age groups most affected include Children ($150.0 - $250.0 Million), Adults ($200.0 - $350.0 Million), and the Elderly ($125.0 - $200.0 Million). Read More

What treatment types are available for viral gastroenteritis, and what are their market valuations?

Treatment types include Supportive Care ($200.0 - $320.0 Million), Antiviral Medications ($150.0 - $240.0 Million), and Hydration Solutions ($125.0 - $240.0 Million). Read More

How does the market for antiviral medications compare to other treatment types?

Antiviral Medications, valued at $150.0 - $240.0 Million, are a significant segment, though Supportive Care leads with $200.0 - $320.0 Million. Read More

What trends are anticipated in the viral gastroenteritis market as it approaches 2035?

As the market approaches 2035, it may experience growth driven by increasing awareness, advancements in treatment options, and a projected valuation of $800.0 Million. Read More

US Viral Gastroenteritis Market

ID: MRFR/Pharma/16781-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Viral Gastroenteritis Market Research Report: By Type of Virus (Norovirus, Rotavirus), By Diagnosis (Physical Examination, Rapid Stool Test), By Drugs (Antibiotics, Antacids, Laxatives, Antimotility Agents), By Indication (Watery Diarrhea, Vomiting) and By End Use (Hospitals, Clinics, Diagnostic Centers, others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Type (USD Million)
  1. 4.1.1 Norovirus
  2. 4.1.2 Rotavirus
  3. 4.1.3 Adenovirus
  4. 4.1.4 Sapovirus
2. 4.2 Food, Beverages & Nutrition, BY Transmission Route (USD Million)
  1. 4.2.1 Fecal-Oral Route
  2. 4.2.2 Contaminated Water
  3. 4.2.3 Contaminated Food
3. 4.3 Food, Beverages & Nutrition, BY Age Group (USD Million)
  1. 4.3.1 Children
  2. 4.3.2 Adults
  3. 4.3.3 Elderly
4. 4.4 Food, Beverages & Nutrition, BY Treatment Type (USD Million)
  1. 4.4.1 Supportive Care
  2. 4.4.2 Antiviral Medications
  3. 4.4.3 Hydration Solutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 GSK (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Merck & Co (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Pfizer (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Sanofi (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bristol-Myers Squibb (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Johnson & Johnson (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 AbbVie (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AstraZeneca (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY TRANSMISSION ROUTE
4. 6.4 US MARKET ANALYSIS BY AGE GROUP
5. 6.5 US MARKET ANALYSIS BY TREATMENT TYPE
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY TRANSMISSION ROUTE, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY TRANSMISSION ROUTE, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY AGE GROUP, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY AGE GROUP, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TRANSMISSION ROUTE, 2025-2035 (USD Million)
  3. 7.2.3 BY AGE GROUP, 2025-2035 (USD Million)
  4. 7.2.4 BY TREATMENT TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

Norovirus
Rotavirus
Adenovirus
Sapovirus

Food, Beverages & Nutrition By Transmission Route (USD Million, 2025-2035)

Fecal-Oral Route
Contaminated Water
Contaminated Food

Food, Beverages & Nutrition By Age Group (USD Million, 2025-2035)

Children
Adults
Elderly

Food, Beverages & Nutrition By Treatment Type (USD Million, 2025-2035)

Supportive Care
Antiviral Medications
Hydration Solutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”